Skip to main content

Month: March 2026

Publication of the English version of the 2025 Universal Registration Document

Nanterre, 11 March 2026 Publication of the English version of the2025 Universal Registration Document The 2025 Universal Registration Document of VINCI is now available in English on the Group’s website at www.vinci.com under Finance/Investors/Financial information/Annual reports.    About VINCIVINCI is a world leader in concessions, energy solutions and construction, employing 294,000 people in more than 120 countries. We design, finance, build and operate infrastructure and facilities that help improve daily life and mobility for all. Because we believe in all-round performance, above and beyond economic and financial results, we are committed to operating in an environmentally and socially responsible manner. And because our projects are in the public interest, we consider that reaching out to all our stakeholders and engaging in dialogue...

Continue reading

GUERBET : 2025 full-year results.

2025 full-year resultsRevenue: €786.4 million, down 3.5% at CER1 and like-for-like2, mainly due to the fall in activity in France Profitability: restated EBITDA margin3 of 12.0% (at the high end of the adjusted range communicated in December) Net Income: loss of €112.7 million, which includes a non-recurring impairment of €86 million Free cash flow: in positive territory at €19.2 million Indebtedness: net debt/EBITDA ratio of 4.0x, below the ceiling of 4.8x set in December 2025 under the waiver obtained by the Group from its lenders.2026Significant negative impact expected from the situation in Raleigh on revenue, profitability, cash generation and group indebtedness with a probable risk of covenant breach on June 30, 2026 No dividend distribution in respect of the 2025 fiscal year Continuation of the transformation plan and strategic...

Continue reading

NEURONES: Net profit, Group share stable in 2025

PRESS INFORMATIONHeading: 2025 annual results        Nanterre, March 11, 2026 (after trading) Net profit, Group share stable in 2025Financial statements at December 31 (1) 2024 2025Revenues 810.4 857.2Business operating profit (2) 84.1 (10.4%) 82.1 (9.6%)Operating profit 77.9 (9.6%) 75.6 (8.8%)Financial profit/loss 10.2 9.5Income tax (24.9) (23.2)Net profit 63.2 (7.8%) 61.9 (7.2%)– of which, group share 52.5 52.1Free cash flow (3) 74.6 62.2Net cash net of financial debt (4) 319.5 336.6Staff at year-end 7,087 7,208(1)        In millions of euros, 2025 financial statements approved by the Board of Directors on March 11, 2026.(2)        Before cost of bonus shares(3)        Cash flow from operational activities, plus financial profit and less net industrial investments.(4)        Excluding IFRS16...

Continue reading

Sogeclair: annual results for 2025

ANNUAL RESULTS FOR 2025Consolidated turnover: €160.3M, +2.1% (at constant exchange rate: +3.0%)EBITDA (1) = €18.7M, +13.0%Net Result = €6.8M, +11.8%Dividend = €1.0 per share, +4.2% Blagnac, France, March 11th, 2026, after closing of the Stock Market. SOGECLAIR, supplier of innovative solutions with high added value for a safer and less-consuming mobility publishes its financial results for the year ended December 31, 2025. SOGECLAIR is listed on Euronext Growth in Paris. The Board of Directors, which met on March 10th, 2026, has approved the financial statements for the year ended December 31, 2025. The audit procedures on the annual accounts have been carried out.All interim management figures improved, with EBITDA at 11.7% of turnover, increasing to €18.7 million, operating income at 6.4% of turnover, up significantly to €10.2 million,...

Continue reading

SANOMA CORPORATION: ACQUISITION OF OWN SHARES 11 March 2026

Sanoma Corporation, Stock exchange release, 11 March 2026 at 18:30 EET SANOMA CORPORATION: ACQUISITION OF OWN SHARES 11 March 2026 Nasdaq Helsinki Ltd:Date 11 March 2026  Exchange transaction Buy  Share class SANOMA  Amount 26,439  Average price/share, EUR 8.9517  Highest price/share, EUR 9.0400  Lowest price/share, EUR 8.8600  Total cost, EUR 236,674.00       The share buybacks are executed in compliance with Regulation No. 596/2014 of the European Parliament and Council (MAR) Article 5 and the Commission Delegated Regulation (EU) 2016/1052. The company holds a total of 795,537 of its own shares (SANOMA) including the shares acquired on 11 March 2026. Detailed information concerning the acquisition is attached to this stock exchange release. On behalf of Sanoma Corporation Skandinaviska Enskilda Banken AB...

Continue reading

Lassila & Tikanoja Plc: Share Repurchase 11.3.2026

Lassila & Tikanoja Plc, STOCK EXCHANGE RELEASE, 11 March 2026 at 6.30 PM (EET)                        Lassila & Tikanoja Plc: Share Repurchase 11.3.2026                 In the Helsinki Stock Exchange                     Trade date           11.3.2026        Bourse trade         Buy        Share                  LASTIK        Amount             12 000 Shares      Average price/ share    7,6953 EUR      Total cost            92 343,60 EUR                            Lassila & Tikanoja Plc now holds a total of 65 712 shares      including the shares repurchased on 11.3.2026                   The share buybacks are executed in compliance with Regulation       No. 596/2014 of the European Parliament and Council (MAR) Article 5    and the Commission Delegated Regulation...

Continue reading

PatentVest Announces Strategic Intellectual Property Collaboration with Porosome Therapeutics to Strengthen Platform for Secretory Disorder Therapeutics

Dallas, TX, March 11, 2026 (GLOBE NEWSWIRE) — PatentVest announced the completion of a strategic intellectual property engagement with Porosome Therapeutics, Inc., a biotechnology company developing a first-in-class therapeutic platform designed to restore cellular secretion mechanisms. The collaboration focused on evaluating and strengthening Porosome Therapeutics’ intellectual property portfolio to support future partnerships, commercialization efforts, and capital strategy initiatives. PatentVest conducted a comprehensive IP portfolio audit, global patent landscape analyses, competitive benchmarking, and strategic partner assessment. Porosome Therapeutics is advancing Porosome Reconstitution Platforms (PRPs), a novel approach to restore cells’ native secretory machinery. Unlike traditional therapies that suppress or modulate...

Continue reading

Initiation of share buyback programme in Gabriel Holding A/S

The Board of Directors of Gabriel Holding A/S has today resolved to repurchase the company’s own shares based on the authorization granted at the Annual General Meeting on 11 December 2025. The authorization is valid for 5 years and up to 20% of the share capital. At the initiation of the share buyback programme, Gabriel Holding A/S holds no treasury shares. The purpose of the share buyback programme is to ensure an appropriate holding of treasury shares, which may be used in connection with acquisitions and/or as the basis for share-based remuneration programmes for key employees of the company. Shares not used for these purposes are expected to be cancelled, resulting in a reduction of the company’s share capital in accordance with the provisions of the Danish Companies Act. The share buyback programme will run from 16 March 2026 through...

Continue reading

Toll Brothers Announces New Luxury Home Community Coming Soon to Mapleton, Utah

Toll Brothers at Mapleton – Heights Collection offers breathtaking views and elegant home designs MAPLETON, Utah, March 11, 2026 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest Utah community, Toll Brothers at Mapleton – Heights Collection, is coming soon to Mapleton, Utah. This highly anticipated community will feature beautiful new construction homes with mountain views in a charming small-town setting. The community is scheduled to open for sale in spring 2026, and the model home will be featured in the 2026 Utah Valley Parade of Homes. A second collection, Toll Brothers at Mapleton – Crest Collection, will open in late summer 2026.Toll Brothers at Mapleton – Heights Collection will feature elegant single- and two-story home...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.